Log in to save to my catalogue

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2818760

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers. These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme’s ability to catalyse conversion of isocitrate to α-ketoglutarate. However, only a single copy of the...

Alternative Titles

Full title

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2818760

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2818760

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/nature08617